» Articles » PMID: 15880397

A Review of the Possible Relevance of Inositol and the Phosphatidylinositol Second Messenger System (PI-cycle) to Psychiatric Disorders--focus on Magnetic Resonance Spectroscopy (MRS) Studies

Overview
Specialty Pharmacology
Date 2005 May 10
PMID 15880397
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Myo-inositol is an important part of the phosphatidylinositol second messenger system (PI-cycle). Abnormalities in nerve cell myo-inositol levels and/or PI-cycle regulation has been suggested as being involved in the pathophysiology and/or treatment of many psychiatric disorders including bipolar disorder, major depressive disorder, panic disorder, obsessive-compulsive disorder, eating disorders and schizophrenia. This review examines the metabolism and biochemical importance of myo-inositol and the PI-cycle. It relates this to the current in vivo evidence for myo-inositol and PI-cycle involvement in these psychiatric disorders, particularly focusing upon the magnetic resonance spectroscopy (MRS) findings in patient studies to date. From this review it is concluded that while the evidence suggests probable relevance to the pathophysiology and/or treatment of bipolar disorder, there is much less support for a significant role for the PI-cycle or myo-inositol in any other psychiatric disorder. More definitive investigation is required before PI-cycle dysfunction can be considered specific to bipolar disorder.

Citing Articles

Alterations in metabolites in the anterior cingulate cortex and thalamus and their associations with pain and empathy in patients with chronic mild pain: a preliminary study.

Shigemura T, Osone F, Hara A, Miyano K, Okada A, Yokokawa T J Neural Transm (Vienna). 2024; 131(9):1079-1094.

PMID: 38896135 DOI: 10.1007/s00702-024-02791-1.


Metabolic alterations in the right anterior insula among patients with cirrhosis without overt hepatic encephalopathy: a magnetic resonance spectroscopy study.

Huang N, Huang H, Dong Q, Wen Y, Li D, Li J Front Neurol. 2024; 14:1291478.

PMID: 38283679 PMC: 10811796. DOI: 10.3389/fneur.2023.1291478.


Neurometabolic alterations in children and adolescents with functional neurological disorder.

Charney M, Foster S, Shukla V, Zhao W, Jiang S, Kozlowska K Neuroimage Clin. 2024; 41:103557.

PMID: 38219534 PMC: 10825645. DOI: 10.1016/j.nicl.2023.103557.


Metabolic Fingerprints of Effective Fluoxetine Treatment in the Prefrontal Cortex of Chronically Socially Isolated Rats: Marker Candidates and Predictive Metabolites.

Filipovic D, Inderhees J, Korda A, Tadic P, Schwaninger M, Inta D Int J Mol Sci. 2023; 24(13).

PMID: 37446133 PMC: 10341512. DOI: 10.3390/ijms241310957.


Basal glutamate in the hippocampus and the dorsolateral prefrontal cortex in schizophrenia: Relationships to cognitive proficiency investigated with structural equation modelling.

Stanley J, Daugherty A, Richter Gorey C, Thomas P, Khatib D, Chowdury A World J Biol Psychiatry. 2023; 24(8):730-740.

PMID: 36999359 PMC: 10591941. DOI: 10.1080/15622975.2023.2197653.